High Plasma Cystine Levels Are Associated with Blood Pressure and Reversed by CPAP in Patients with Obstructive Sleep Apnea.

Obstructive sleep apnea (OSA) independent of obesity (OBS) imposes severe cardiovascular risk. To what extent plasma cystine concentration (CySS), a novel pro-oxidative vascular risk factor, is increased in OSA with or without OBS is presently unknown. We therefore studied CySS together with the redox state and precursor amino acids of glutathione (GSH) in peripheral blood mononuclear cells (PBMC) in untreated male patients with OSA (apnea-hypopnea-index (AHI) > 15 h, = 28) compared to healthy male controls ( = 25) stratifying for BMI ≥ or < 30 kg m. Fifteen OSA patients were reassessed after 3-5-months CPAP. CySS correlated with cumulative time at an O-saturation <90% (Tu90%) (r = 0.34, < 0.05) beside BMI (r = 0.58, < 0.001) and was higher in subjects with "hypoxic stress" (59.4 ± 2.0 vs. 50.1 ± 2.7 µM, < 0.01) defined as Tu90% ≥ 15.2 min (corresponding to AHI ≥ 15 h). Moreover, CySS significantly correlated with systolic (r = 0.32, < 0.05) and diastolic (r = 0.31, < 0.05) blood pressure. CPAP significantly lowered CySS along with blood pressure at unchanged BMI. Unexpectedly, GSH antioxidant capacity in PBMC was increased with OSA and reversed with CPAP. Plasma CySS levels are increased with OSA-related hypoxic stress and associated with higher blood pressure. CPAP decreases both CySS and blood pressure. The role of CySS in OSA-related vascular endpoints and their prevention by CPAP warrants further studies.